BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14183105)

  • 1. THE SELECTIVE ACTION IN CULTURE OF SOME TRYPANOCIDAL DRUGS ON TRYPANOSOMA RHODESIENSE AND T. BRUCEI.
    LEHMANN DL
    Ann Trop Med Parasitol; 1964 Jun; 58():189-91. PubMed ID: 14183105
    [No Abstract]   [Full Text] [Related]  

  • 2. [SLEEPING SICKNESS DUE TO TRYPANOSOMA RHODESIENSE IN RWANDA-BURUNDI].
    EVENS F
    Ann Soc Belg Med Trop (1920); 1963 Oct; 43():843-52. PubMed ID: 14122092
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug effects on the fine structure of Trypanosoma rhodesiense: suramin, tryparsamide and mapharside.
    Macadam RF; Williamson J
    Ann Trop Med Parasitol; 1974 Sep; 68(3):301-6. PubMed ID: 4280885
    [No Abstract]   [Full Text] [Related]  

  • 4. [In vivo resistance to strains of Trypanosoma rhodesiense, Mozambique, 1985].
    Pérez Martín O; Lastre González M; Urban M; Shwalbach J
    Rev Cubana Med Trop; 1991; 43(3):189-93. PubMed ID: 9768188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug resistance in trapanososmes: cross-resitance analyses.
    WILLIAMSON J; ROLLO IM
    Br J Pharmacol Chemother; 1959 Dec; 14(4):423-30. PubMed ID: 13844958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The action of trypanocidal arsenical drugs on Trypanosoma brucei and Trypanosoma rhodesiense.
    Flynn IW; Bowman IB
    Comp Biochem Physiol B; 1974 Jun; 48(2):261-73. PubMed ID: 4833120
    [No Abstract]   [Full Text] [Related]  

  • 7. The trypanocidal activity of some pyrimidylaminophenylarsonic compounds.
    AINLEY AD; DAVEY DG
    Br J Pharmacol Chemother; 1958 Sep; 13(3):244-9. PubMed ID: 13584724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of methionine transport and metabolism by Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense.
    Goldberg B; Rattendi D; Lloyd D; Yarlett N; Bacchi CJ
    Arch Biochem Biophys; 2000 May; 377(1):49-57. PubMed ID: 10775440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate lack of susceptibility of Ugandan Trypanosoma brucei rhodesiense to DL-alpha-difluoromethylornithine (DFMO).
    Iten M; Matovu E; Brun R; Kaminsky R
    Trop Med Parasitol; 1995 Sep; 46(3):190-4. PubMed ID: 8533023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiprotozoal activity of Khaya anthotheca, (Welv.) C.D.C. a plant used by chimpanzees for self-medication.
    Obbo CJ; Makanga B; Mulholland DA; Coombes PH; Brun R
    J Ethnopharmacol; 2013 May; 147(1):220-3. PubMed ID: 23501156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis.
    Nok AJ
    Parasitol Res; 2003 May; 90(1):71-9. PubMed ID: 12743807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of late stage rhodesiense trypanosomiasis using suramin and eflornithine: report of six cases.
    Clerinx J; Taelman H; Bogaerts J; Vervoort T
    Trans R Soc Trop Med Hyg; 1998; 92(4):449-50. PubMed ID: 9850406
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug-resistance of Trypanosoma b. rhodesiense isolates from Tanzania.
    Kibona SN; Matemba L; Kaboya JS; Lubega GW
    Trop Med Int Health; 2006 Feb; 11(2):144-55. PubMed ID: 16451338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance of Trypanosoma evansi to quinapyramine, suramin, stilbamidine and tryparsamide and analysis of cross-resistance.
    Gill BS
    Trans R Soc Trop Med Hyg; 1971; 65(3):352-7. PubMed ID: 4254332
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro trypanocidal activity of dibutyltin dichloride and its fatty acid derivatives.
    Shuaibu MN; Kanbara H; Yanagi T; Ichinose A; Ameh DA; Bonire JJ; Nok AJ
    Parasitol Res; 2003 Sep; 91(1):5-11. PubMed ID: 12851812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic and old taxa: subspeciation and drug sensitivity in Trypanosoma brucei.
    Dukes P
    Trans R Soc Trop Med Hyg; 1984; 78(6):711-25. PubMed ID: 6241967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metronidazole and suramin combination in the treatment of arsenical refractory Rhodesian sleeping sickness--a case study.
    Foulkes JR
    Trans R Soc Trop Med Hyg; 1996; 90(4):422. PubMed ID: 8882195
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluating the impact of targeting livestock for the prevention of human and animal trypanosomiasis, at village level, in districts newly affected with T. b. rhodesiense in Uganda.
    Hamill L; Picozzi K; Fyfe J; von Wissmann B; Wastling S; Wardrop N; Selby R; Acup CA; Bardosh KL; Muhanguzi D; Kabasa JD; Waiswa C; Welburn SC
    Infect Dis Poverty; 2017 Feb; 6(1):16. PubMed ID: 28162093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and in vitro antiprotozoal activities of water-soluble, inexpensive 3,7-bis(dialkylamino)phenoxazin-5-ium derivatives.
    Ge JF; Arai C; Kaiser M; Wittlin S; Brun R; Ihara M
    J Med Chem; 2008 Jun; 51(12):3654-8. PubMed ID: 18476684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cynaropicrin: the first plant natural product with in vivo activity against Trypanosoma brucei.
    Zimmermann S; Kaiser M; Brun R; Hamburger M; Adams M
    Planta Med; 2012 Apr; 78(6):553-6. PubMed ID: 22331812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.